CSBR
Champions Oncology Exceeds Expectations in Q1 2027: Revenue and Margins Surge
Champions Oncology, a leading provider of translational oncology services and data solutions, has reported a robust first quarter for fiscal 2027. In a recent conference call, CEO Rob Brainin highlighted the company's strong performance, which exceeded expectations. The company achieved revenue of $15.2 million in Q1 2027,